Medical Center Vita 1 Ltd.
- Address
- Ulitsa Georgi Kochev 39, 5809 Pleven, Bulgaria
Medical Center Vita 1 Ltd. - Neurological Disorders Research Center
Medical Center Vita 1 Ltd. is a specialized clinical research facility dedicated to advancing treatment options for complex neurological conditions. The center demonstrates particular expertise in conducting Phase 3 trials for challenging disorders of the central nervous system, focusing on conditions that significantly impact quality of life and require innovative therapeutic approaches.
- Drug-resistant focal onset seizures and refractory partial onset epilepsy
- Parkinson's disease with focus on long-term safety evaluation of novel therapeutic agents
- Relapsing multiple sclerosis and disease-modifying treatments
The research center excels in evaluating both extended-release formulations and investigational compounds across various neurological indications. Their portfolio includes comparative efficacy studies in epilepsy, long-term safety assessments for movement disorders, and multi-center international trials for autoimmune neurological conditions. This comprehensive approach positions Medical Center Vita 1 Ltd. as a key contributor to developing next-generation therapies for patients with treatment-resistant or progressive neurological diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Neuraxpharm Pharmaceuticals S.L.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center Vita 1 Ltd.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Long-Term Safety and Tolerability of Tavapadon in Patients with Parkinson's Disease: A 58-Week Open-Label Multinational Study | Cerevel Therapeutics LLC | Phase III | Not Recruiting | May 2021 | Dec 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Levetiracetam | 1 | Unknown | 2025-03-12 | 2025-03-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.